Urinary F2-Isoprostane Concentration as a Poor Prognostic Factor After Subarachnoid Hemorrhage.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  World Neurosurgery

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.wneu.2017.07.145PMID 28782688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ggplot2 - Elegant Graphics for Data Analysis (2nd Edition)

  2017cited by this paper
• Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.

  2017cited by this paper
• ω-3 Fatty Acids Ethyl Esters Suppress Cerebral Vasospasm and Improve Clinical Outcome Following Aneurysmal Subarachnoid Hemorrhage.

  2017cited by this paper
• Vasospasm: my first 25 years-what worked? what didn't? what next?

  2015cited by this paper
• Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.

  2013cited by this paper
• Early Inhibition of Natriuresis Suppresses Symptomatic Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage

  2013cited by this paper
• Determinants of poor outcome after aneurysmal subarachnoid hemorrhage when both clipping and coiling are available: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan.

  2011cited by this paper
• Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis

  2011cited by this paper
• Angiographic Vasospasm Is Strongly Correlated With Cerebral Infarction After Subarachnoid Hemorrhage

  2011cited by this paper
• pROC: an open-source package for R and S+ to analyze and compare ROC curves

  2011cited by this paper
• Rapid quantitative analysis of 8-iso-prostaglandin-F(2alpha) using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method.

  2010cited by this paper
• An R Companion to Applied Regression

  2010cited by this paper
• Cognitive and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage

  2010cited by this paper
• Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Putative mechanisms and novel approaches

  2009cited by this paper
• Women and Smokers Have Elevated Urinary F2-Isoprostane Metabolites: A Novel Extraction and LC–MS Methodology

  2008cited by this paper
• Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm.

  2008cited by this paper
• F2-isoprostanes are not just markers of oxidative stress.

  2008cited by this paper
• Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage

  2007cited by this paper
• Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends

  2007cited by this paper
• Metabolism and function of coenzyme Q.

  2004cited by this paper
• Plasma 8-Isoprostane Is Increased in Preterm Infants Who Develop Bronchopulmonary Dysplasia or Periventricular Leukomalacia

  2004cited by this paper
• Preventive effects of intracisternal alphatochopherol on cerebral vasospasm in experimental subarachnoid haemorrhage.

  2003cited by this paper
• Nonenzymatic derived lipid peroxide, 8-iso-PGF2α, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model

  2002cited by this paper
• Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage:: The Fisher Scale Revisited

  2001cited by this paper
• Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay.

  2001cited by this paper
• Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy.

  2000cited by this paper
• Cardiovascular Responses to the Isoprostanes iPF2α-III and iPE2-III Are Mediated via the Thromboxane A2 Receptor In Vivo

  2000cited by this paper
• Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo.

  2000cited by this paper
• Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels.

  1999cited by this paper
• In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

  1999cited by this paper
• Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress.

  1999cited by this paper
• Increased urinary F2-isoprostane excretion in alcoholic liver disease.

  1999cited by this paper
• Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor.

  1999cited by this paper
• Increased lipid peroxidation in patients with rhabdomyolysis.

  1999cited by this paper
• Cerebrospinal fluid F2-isoprostanes are elevated in Huntington’s disease

  1999cited by this paper
• Increased CSF F2-isoprostane concentration in probable AD

  1999cited by this paper
• Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.

  1999cited by this paper
• Isoprostanes as Markers of Lipid Peroxidation in Atherosclerosis

  1999cited by this paper
• Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry

  1999cited by this paper
• In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus

  1999cited by this paper
• Metabolism of 8‐iso‐prostaglandin F2α

  1998cited by this paper
• Cyclooxygenase inhibition aggravates ischemia-reperfusion injury in the perfused guinea pig heart: involvement of isoprostanes.

  1998cited by this paper
• Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

  1998cited by this paper
• Increased F2‐isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo

  1998cited by this paper
• Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS.

  1998cited by this paper
• A Causative Role for Redox Cycling of Myoglobin and Its Inhibition by Alkalinization in the Pathogenesis and Treatment of Rhabdomyolysis-induced Renal Failure*

  1998cited by this paper
• Cerebrospinal fluid F2‐isoprostane levels are increased in Alzheimer's disease

  1998cited by this paper
• A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2α on retinal vessels.

  1998cited by this paper
• Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

  1998cited by this paper
• Antioxidant status and alpha1-antiproteinase activity in subarachnoid hemorrhage patients.

  1998cited by this paper
• Metabolism of 8-iso-prostaglandin F2alpha.

  1998cited by this paper
• A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels.

  1998cited by this paper
• The generation and actions of isoprostanes.

  1997cited by this paper
• Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.

  1997cited by this paper
• Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.

  1997cited by this paper
• Oral coenzyme Q10 administration prevents the development of ischemic brain lesions in a rabbit model of symptomatic vasospasm

  1997cited by this paper
• F2-isoprostane and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders.

  1997cited by this paper
• Increased Formation of the Isoprostanes IPF2α-I and 8-Epi-Prostaglandin F2α in Acute Coronary Angioplasty

  1997cited by this paper
• 8-Epi PGF2α Generation During Coronary Reperfusion

  1997cited by this paper
• 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.

  1997cited by this paper
• Modulation of oxidant stress in vivo in chronic cigarette smokers.

  1996cited by this paper
• Antioxidants in human health and disease.

  1996cited by this paper
• Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.

  1995cited by this paper
• Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus

  1995cited by this paper
• Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease.

  1994cited by this paper
• Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

  1994cited by this paper
• Lipid peroxidation as molecular mechanism of liver cell injury during reperfusion after ischemia.

  1994cited by this paper
• Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome.

  1993cited by this paper
• Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.

  1992cited by this paper
• A review of hemoglobin and the pathogenesis of cerebral vasospasm.

  1991cited by this paper
• Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids.

  1990cited by this paper
• The effects of chronic two-fold dietary vitamin E supplementation on subarachnoid hemorrhage-induced brain hypoperfusion.

  1987cited by this paper
• Free radicals in biology and medicine

  1985cited by this paper
• Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

  1980cited by this paper
• Assessment of outcome after severe brain damage.

  1975cited by this paper
• Assessment of coma and impaired consciousness. A practical scale.

  1974cited by this paper
• MANAGEMENT OF VIRUS HEPATITIS.

  1964cited by this paper

• Lipid peroxidation metabolites as biomarkers in patients with aneurysmal subarachnoid hemorrhage and cerebral vasospasm or delayed cerebral ischemia: a systematic review

  2025cites this paper
• The role of potential oxidative biomarkers in the prognosis of intracerebral hemorrhage and the exploration antioxidants as possible preventive and treatment options

  2025cites this paper
• Dietary antioxidant capacity is inversely associated with F2- isoprostane and body fat percentage in elite soccer referees

  2024cites this paper
• Laboratory biomarkers of delayed cerebral ischemia following subarachnoid hemorrhage: A systematic review

  2023cites this paper
• Biomarkers in aneurysmal subarachnoid hemorrhage: A short review

  2023cites this paper
• Isofurans and Isoprostanes as Potential Markers of Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Observational Study

  2021cites this paper
• Isofurans and isoprostanes as markers of delayed brain injury and mitochondrial dysfunction following aneurysmal subarachnoid hemorrhage. A prospective observational study

  2021cites this paper
• The Role of Urine F2-isoprostane Concentration in Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Haemorrhage—A Poor Prognostic Factor

  2020cites this paper
• Isoprostanes as potential cerebral vasospasm biomarkers.

  2018cites this paper